Budas, Renalyn E.
HRN: 13-35-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2025
CEFUROXIME 500MG (TAB)
02/22/2025
03/01/2025
ORAL
500 Mg/tab
Bid
S/p Completion Curretage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes